These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 24098750)

  • 1. Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism.
    Nakahara M; Ito T; Kawahara K; Yamamoto M; Nagasato T; Shrestha B; Yamada S; Miyauchi T; Higuchi K; Takenaka T; Yasuda T; Matsunaga A; Kakihana Y; Hashiguchi T; Kanmura Y; Maruyama I
    PLoS One; 2013; 8(9):e75961. PubMed ID: 24098750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Recombinant Human Soluble Thrombomodulin on Coagulation-Related Variables in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Retrospective Observational Study.
    Mitaka C; Kawagoe I; Satoh D; Hayashida M
    Clin Appl Thromb Hemost; 2021; 27():10760296211050356. PubMed ID: 34859680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Thrombomodulin Suppresses Histone-Induced Neutrophil Extracellular Trap Formation.
    Shrestha B; Ito T; Kakuuchi M; Totoki T; Nagasato T; Yamamoto M; Maruyama I
    Front Immunol; 2019; 10():2535. PubMed ID: 31736962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
    Akahoshi T; Sugimori H; Kaku N; Tokuda K; Nagata T; Noda E; Morita M; Hashizume M; Maehara Y
    Eur J Trauma Emerg Surg; 2015 Oct; 41(5):531-8. PubMed ID: 26038004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis.
    Ogura T; Eguchi T; Amano M; Sano T; Nishioka N; Miyano A; Tsujimae M; Tanimura H; Yamada T; Terashima Y; Okada A; Higuchi K
    Thromb Res; 2019 Apr; 176():74-78. PubMed ID: 30780007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology field.
    Ito T; Nagahara A; Osada T; Kato J; Ueyama H; Saito H; Taniki N; Kanazawa R; Shimizu R; Sai J; Shiina S; Watanabe S
    Biomed Rep; 2015 Jul; 3(4):457-460. PubMed ID: 26171148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
    Ookura M; Hosono N; Tasaki T; Oiwa K; Fujita K; Ito K; Lee S; Matsuda Y; Morita M; Tai K; Negoro E; Kishi S; Iwasaki H; Ueda T; Yamauchi T
    Medicine (Baltimore); 2018 Nov; 97(44):e12981. PubMed ID: 30383650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin generation mediators and markers in sepsis-associated coagulopathy and their modulation by recombinant thrombomodulin.
    Hoppensteadt D; Tsuruta K; Cunanan J; Hirman J; Kaul I; Osawa Y; Fareed J
    Clin Appl Thromb Hemost; 2014 Mar; 20(2):129-35. PubMed ID: 23804232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombomodulin as a Physiological Modulator of Intravascular Injury.
    Watanabe-Kusunoki K; Nakazawa D; Ishizu A; Atsumi T
    Front Immunol; 2020; 11():575890. PubMed ID: 33042158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of Recombinant Thrombomodulin for Sepsis-Associated Disseminated Intravascular Coagulation Caused by Urinary Tract Infections].
    Tachibana A; Iida K; Itami Y; Hashimura M; Toyoshima Y; Hosokawa Y; Fujimoto K
    Hinyokika Kiyo; 2023 Nov; 69(11):309-314. PubMed ID: 38031329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of sepsis-induced disseminated intravascular coagulation in a patient with idiopathic thrombocytopenic purpura using recombinant human soluble thrombomodulin.
    Koga T; Inoue D; Okada A; Aramaki T; Yamasaki S; Nakashima M; Kawakami A; Eguchi K
    Rheumatol Int; 2011 Dec; 31(12):1657-9. PubMed ID: 21240494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
    Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
    Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors.
    Ouchi K; Takahashi S; Chikamatsu S; Ito S; Takahashi Y; Kawai S; Okita A; Kasahara Y; Okada Y; Imai H; Komine K; Saijo K; Takahashi M; Shirota H; Takahashi M; Gamoh M; Ishioka C
    Int J Clin Oncol; 2018 Aug; 23(4):790-798. PubMed ID: 29511940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis.
    Okuda A; Ogura T; Imanishi M; Miyano A; Nishioka N; Higuchi K
    Gut Liver; 2018 Jul; 12(4):471-477. PubMed ID: 29699063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of thrombomodulin in sepsis-associated DIC].
    Ito T
    Rinsho Ketsueki; 2016 Apr; 57(4):405-11. PubMed ID: 27169442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Bleeding Risk of Antithrombin Supplementation in Patients With Septic Disseminated Intravascular Coagulation: A Third Survey.
    Iba T; Gando S; Saitoh D; Ikeda T; Anan H; Oda S; Kitamura N; Mori S; Kotani J; Kuroda Y
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):422-428. PubMed ID: 27161759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human thrombomodulin for pneumonia-induced severe ARDS complicated by DIC in children: a preliminary study.
    Hirata N; Ngo DT; Phan PH; Ainai A; Phung TTB; Ta TA; Takasaki J; Kawachi S; Nunoi H; Nakajima N; Dien TM
    J Anesth; 2021 Oct; 35(5):638-645. PubMed ID: 34259911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study.
    Asai Y; Yamamoto T; Kito D; Ichikawa K; Abe Y
    J Pharm Health Care Sci; 2020 Dec; 6(1):26. PubMed ID: 33292809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation.
    Suetani K; Okuse C; Nakahara K; Michikawa Y; Noguchi Y; Suzuki M; Morita R; Sato N; Kato M; Itoh F
    World J Gastroenterol; 2015 Jan; 21(2):533-40. PubMed ID: 25593469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human soluble thrombomodulin is associated with attenuation of sepsis-induced renal impairment by inhibition of extracellular histone release.
    Akatsuka M; Masuda Y; Tatsumi H; Yamakage M
    PLoS One; 2020; 15(1):e0228093. PubMed ID: 31971961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.